Celldex Therapeutics, Inc. - stock earnings
CLDX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.83 / -0.71 | - | - / 934065 | - |
CLDX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -50.3 million USD | 4.1 million USD |
| 2023Q3 | -38.3 million USD | 1.5 million USD |
| 2023Q2 | -30.5 million USD | 268000 USD |
| 2023Q1 | -22.4 million USD | 967000 USD |
| 2022Q4 | -23.7 million USD | 1.6 million USD |
| 2022Q3 | -25.0 million USD | 407000 USD |
| 2022Q2 | -52.6 million USD | 163000 USD |
| 2022Q1 | -21.6 million USD | 174000 USD |
| 2021Q4 | -20.1 million USD | 333000 USD |
| 2021Q3 | -20.5 million USD | 153000 USD |
| 2021Q2 | -13.4 million USD | 3.5 million USD |
| 2021Q1 | -16.5 million USD | 685000 USD |
| 2020Q4 | -21.9 million USD | 3.8 million USD |
| 2020Q3 | -14.2 million USD | 668000 USD |
| 2020Q2 | -11.0 million USD | 236000 USD |
| 2020Q1 | -12.6 million USD | 2.7 million USD |
| 2019Q4 | -10.4 million USD | 887000 USD |
| 2019Q3 | -11.4 million USD | 546000 USD |
| 2019Q2 | -11.8 million USD | 715000 USD |
| 2019Q1 | -17.2 million USD | 1.4 million USD |
| 2018Q4 | -9.4 million USD | 1.8 million USD |
| 2018Q3 | -7.2 million USD | 941000 USD |
| 2018Q2 | -16.4 million USD | 2.8 million USD |
| 2018Q1 | -118.1 million USD | 4.1 million USD |
| 2017Q4 | -3.8 million USD | 3.5 million USD |
| 2017Q3 | -26.4 million USD | 3.9 million USD |
| 2017Q2 | -28.6 million USD | 3.8 million USD |
| 2017Q1 | -34.3 million USD | 1.5 million USD |
| 2016Q4 | -32.3 million USD | 1.9 million USD |
| 2016Q3 | -29.6 million USD | 2.2 million USD |
| 2016Q2 | -32.0 million USD | 1.4 million USD |
| 2016Q1 | -34.7 million USD | 1.3 million USD |
| 2015Q4 | -32.7 million USD | 1.8 million USD |
| 2015Q3 | -32.0 million USD | 1.0 million USD |
| 2015Q2 | -32.4 million USD | 2.2 million USD |
| 2015Q1 | -30.2 million USD | 486000 USD |
| 2014Q4 | -31.8 million USD | 1.5 million USD |
| 2014Q3 | -28.1 million USD | 1.1 million USD |
| 2014Q2 | -28.3 million USD | 592000 USD |
| 2014Q1 | -29.9 million USD | 416000 USD |
| 2013Q4 | -22.1 million USD | 620000 USD |
| 2013Q3 | -23.1 million USD | 980000 USD |
| 2013Q2 | -19.0 million USD | 97000 USD |
| 2013Q1 | -17.3 million USD | 2.4 million USD |
| 2012Q4 | -16.8 million USD | 3.6 million USD |
| 2012Q3 | -15.0 million USD | 3.1 million USD |
| 2012Q2 | -13.8 million USD | 2.0 million USD |
| 2012Q1 | -13.5 million USD | 2.4 million USD |
| 2011Q4 | -12.7 million USD | 2.4 million USD |
| 2011Q3 | -11.8 million USD | 2.4 million USD |
| 2011Q2 | -10.2 million USD | 2.0 million USD |
| 2011Q1 | -10.1 million USD | 2.5 million USD |
| 2010Q4 | 22.7 million USD | 37.7 million USD |
| 2010Q3 | -9.1 million USD | 2.4 million USD |
| 2010Q2 | -9.5 million USD | 3.0 million USD |
| 2010Q1 | -6.6 million USD | 3.7 million USD |
| 2009Q4 | -12.9 million USD | 4.7 million USD |
| 2009Q3 | -7.2 million USD | 4.0 million USD |
| 2009Q2 | -8.7 million USD | 2.7 million USD |
| 2009Q1 | -7.7 million USD | 3.7 million USD |
| 2008Q4 | -7.5 million USD | 3.0 million USD |
| 2008Q3 | -7.7 million USD | 2.4 million USD |
| 2008Q2 | -10.3 million USD | 2.0 million USD |
| 2008Q1 | -22.1 million USD | 147398 USD |
| 2007Q4 | -5.3 million USD | 1.7 million USD |
| 2007Q3 | -5.3 million USD | 1.2 million USD |
| 2007Q2 | -5.5 million USD | 1.0 million USD |
| 2007Q1 | -5.6 million USD | 1.2 million USD |
| 2006Q4 | -6.2 million USD | 380132 USD |
| 2006Q3 | -5.5 million USD | 338999 USD |
| 2006Q2 | -5.7 million USD | 505479 USD |
| 2006Q1 | -3.0 million USD | 3.7 million USD |
| 2005Q4 | -4.0 million USD | 634306 USD |
| 2005Q3 | -4.5 million USD | 846322 USD |
| 2005Q2 | -4.7 million USD | 637161 USD |
| 2005Q1 | -4.9 million USD | 970552 USD |
| 2004Q4 | -3.7 million USD | 2.4 million USD |
| 2004Q3 | -3.7 million USD | 527600 USD |
| 2004Q2 | -3.9 million USD | 893000 USD |
| 2004Q1 | -1.9 million USD | 3.0 million USD |
| 2003Q4 | -4.0 million USD | 857700 USD |
| 2003Q3 | -2.1 million USD | 2.0 million USD |
| 2003Q2 | -3.2 million USD | 1.1 million USD |
| 2003Q1 | -3.4 million USD | 681700 USD |
| 2002Q4 | -3.5 million USD | 810800 USD |
| 2002Q3 | -276200 USD | 4.6 million USD |
| 2002Q2 | -5.2 million USD | 642800 USD |
| 2002Q1 | -4.9 million USD | 690900 USD |
| 2001Q4 | -6.9 million USD | 935700 USD |
| 2001Q3 | -6.2 million USD | 725500 USD |
| 2001Q2 | -5.7 million USD | 825800 USD |
| 2001Q1 | -4.0 million USD | 859000 USD |
| 2000Q4 | -13.5 million USD | 301600 USD |
| 2000Q3 | -3.6 million USD | 153900 USD |
| 2000Q2 | -2.7 million USD | 153900 USD |
| 2000Q1 | -2.1 million USD | 153800 USD |
| 1999Q4 | -3.6 million USD | -16500 USD |
| 1999Q3 | -2.6 million USD | 300000 USD |
| 1999Q2 | -2.4 million USD | 900000 USD |
| 1999Q1 | -2.7 million USD | 300000 USD |
| 1998Q4 | -2.3 million USD | 1.1 million USD |
| 1998Q3 | -46.8 million USD | 400000 USD |
| 1998Q2 | -1.3 million USD | 300000 USD |
| 1998Q1 | -1.4 million USD | 400000 USD |
| 1997Q4 | -1.5 million USD | 400000 USD |
| 1997Q3 | -8.0 million USD | 100000 USD |
| 1997Q2 | -1.7 million USD | 700000 USD |
| 1997Q1 | -1.9 million USD | 100000 USD |
| 1996Q4 | -2.4 million USD | 300000 USD |
| 1996Q3 | -2.3 million USD | 100000 USD |
| 1996Q2 | -4.3 million USD | 200000 USD |
| 1996Q1 | -200000 USD | 900000 USD |
| 1995Q4 | -200000 USD | 900000 USD |
| 1995Q3 | -3.1 million USD | 800000 USD |
| 1995Q2 | -2.6 million USD | 1.2 million USD |
| 1995Q1 | -2.4 million USD | 1.2 million USD |
| 1994Q4 | -4.4 million USD | 1.0 million USD |
| 1994Q3 | -3.0 million USD | 1.5 million USD |
| 1994Q2 | -2.3 million USD | 2.2 million USD |
| 1994Q1 | -1.9 million USD | 2.3 million USD |
| 1993Q4 | -2.2 million USD | 2.2 million USD |
| 1993Q3 | -2.4 million USD | 2.1 million USD |
| 1993Q2 | -1.5 million USD | 2.6 million USD |
| 1993Q1 | -1.7 million USD | 2.2 million USD |
| 1992Q3 | -1.1 million USD | 2.9 million USD |
| 1992Q2 | -1.2 million USD | 2.4 million USD |
| 1992Q1 | -1.4 million USD | 2.4 million USD |
| 1991Q4 | -400000 USD | 3.1 million USD |
| 1991Q3 | -1.5 million USD | 1.7 million USD |
| 1991Q2 | -1.3 million USD | 1.7 million USD |
| 1991Q1 | -900000 USD | 2.5 million USD |
| 1990Q4 | -800000 USD | 2.6 million USD |
| 1990Q3 | -700000 USD | 2.6 million USD |
| 1990Q2 | -1.0 million USD | 2.5 million USD |
| 1990Q1 | 300000 USD | 3.4 million USD |
| 1989Q4 | ? USD | 3.5 million USD |
| 1989Q3 | ? USD | 2.4 million USD |
| 1989Q2 | ? USD | 2.1 million USD |
| 1989Q1 | ? USD | 2.3 million USD |
| 1988Q4 | ? USD | 1.9 million USD |
| 1988Q3 | ? USD | 1.9 million USD |
| 1988Q2 | ? USD | 1.7 million USD |
| 1988Q1 | ? USD | 800000 USD |
| 1987Q4 | ? USD | 1.5 million USD |
| 1987Q3 | ? USD | 1.2 million USD |
| 1987Q2 | ? USD | 1.0 million USD |
| 1987Q1 | ? USD | 200000 USD |
| 1986Q4 | ? USD | 800000 USD |
| 1986Q3 | ? USD | 600000 USD |
| 1986Q2 | ? USD | 200000 USD |
| 1985Q4 | ? USD | 100000 USD |
| 1985Q3 | ? USD | 100000 USD |
CLDX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -141.4 million USD | 6.9 million USD |
| 2022 | -122.8 million USD | 2.4 million USD |
| 2021 | -70.5 million USD | 4.7 million USD |
| 2020 | -59.8 million USD | 7.4 million USD |
| 2019 | -50.4 million USD | 3.6 million USD |
| 2018 | -151.2 million USD | 9.5 million USD |
| 2017 | -93.0 million USD | 12.7 million USD |
| 2016 | -128.5 million USD | 6.8 million USD |
| 2015 | -127.2 million USD | 5.5 million USD |
| 2014 | -118.1 million USD | 3.6 million USD |
| 2013 | -81.6 million USD | 4.1 million USD |
| 2012 | -59.1 million USD | 11.2 million USD |
| 2011 | -44.8 million USD | 9.3 million USD |
| 2010 | -2.5 million USD | 46.8 million USD |
| 2009 | -36.5 million USD | 15.2 million USD |
| 2008 | -47.5 million USD | 7.5 million USD |
| 2007 | -21.6 million USD | 5.1 million USD |
| 2006 | -20.4 million USD | 4.9 million USD |
| 2005 | -18.1 million USD | 3.1 million USD |
| 2004 | -13.2 million USD | 6.9 million USD |
| 2003 | -12.7 million USD | 4.6 million USD |
| 2002 | -13.8 million USD | 6.7 million USD |
| 2001 | -22.8 million USD | 3.3 million USD |
| 2000 | -22.0 million USD | 763200 USD |
| 1999 | -11.3 million USD | 1.5 million USD |
| 1998 | -51.8 million USD | 2.2 million USD |
| 1997 | -13.1 million USD | 1.2 million USD |
| 1996 | -10.8 million USD | 1.1 million USD |
| 1995 | -8.3 million USD | 4.0 million USD |
| 1994 | -11.6 million USD | 7.0 million USD |
| 1993 | -7.8 million USD | 9.0 million USD |
| 1992 | -3.6 million USD | 6.6 million USD |
| 1991 | -4.6 million USD | 8.9 million USD |
| 1990 | -3.4 million USD | 10.2 million USD |
| 1989 | -1.0 million USD | 10.9 million USD |
| 1988 | -1.1 million USD | 7.8 million USD |
| 1987 | -1.2 million USD | 4.6 million USD |
| 1986 | -800000 USD | 2.2 million USD |
| 1985 | -1.7 million USD | 100000 USD |
CLDX
Price: $42.56
52 week price:
Earnings Per Share: -2.86 USD
P/E Ratio: -13.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 2.7 billion